Neoadjuvant chemotherapy with Vinorelbine and Epirubicin in locally advanced breast cancer (LABC).

被引：0
|
作者：
Puerto, VL
Cardenas, J
Lara, F
Goana, R
Silva, A
Barroso, N
机构：
[1] IMSS CMN Siglo XXI, Mexico City, DF, Mexico
[2] Ctr Estatal Cancerol, Colima, Mexico
[3] INCAN, Tlalpan, Mexico
[4] Hosp Gen Dr M Silva, Morelia, Michoacan, Mexico
[5] Hosp Dr A Leano, Zapopan, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
512
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [1] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [2] Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
    Nisticò, C
    De Matteis, A
    Ross, E
    Carnino, F
    Valenza, R
    Agostara, B
    Bria, E
    Farris, A
    Cremonesi, M
    D'Ottavio, AM
    Vaccaro, A
    Garufi, C
    Giunta, S
    Botti, C
    Perrone, F
    Terzoli, E
    [J]. ANTICANCER RESEARCH, 2005, 25 (2B) : 1343 - 1348
  • [3] Combination of vinorelbine, epirubicin, and cyclophosphamide as Neoadjuvant chemotherapy for locally advanced breast cancer - Phase II study
    Braud, AC
    Levy, E
    Feuilhade, F
    Otmezguine, Y
    Calitchi, E
    Kirova, Y
    Le Bourgeois, JP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (03): : 303 - 307
  • [4] Vinorelbine and farmorubicin as neoadjuvant chemotherapy in locally advanced breast cancer
    Gaafar, RM
    Hamza, MR
    ElZawahry, H
    Khaled, H
    Helal, A
    Eissa, S
    AbdelBaki, H
    ElKalaawy, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S329 - S329
  • [5] Phase II study of neaodajuvant chemotherapy combining epirubicin cyclophosphamide and vinorelbine (NEC) in locally advanced breast cancer (LABC): Preliminary results
    Braud, AC
    Jauffret, E
    Kirova, YM
    Piedbois, P
    Levy, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S206 - S206
  • [6] Induction preoperative chemotherapy with high-dose epirubicin in locally advanced breast cancer (LABC)
    Silvestro, P
    DAiuto, G
    Caparrotti, G
    Menditto, C
    Tambaro, R
    Rinaldi, L
    Pergola, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 713 - 713
  • [7] Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
    Abramova, Natalya A.
    Vladimirova, Liubov Yu
    Shikhliarova, Alla I.
    Storozhakova, Anna E.
    Kova, Valeriya S. Myag
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST-CANCER (LABC)
    SWAIN, S
    LIPPMAN, M
    BAGLEY, C
    SORACE, R
    WESLEY, M
    [J]. CANCER DRUG DELIVERY, 1986, 3 (01): : 55 - 55
  • [9] Locally advanced breast cancer (LABC): Neoadjuvant chemotherapy with sequential doxorubicine (DOX) and docetaxel (DOC).
    Wynendaele, W
    Paridaens, R
    Wildiers, J
    Christiaens, MR
    Van den Bogaert, W
    van Oosterom, AT
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S208 - S208
  • [10] Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)?
    Seno, R
    Sparano, JA
    Fineberg, S
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 121 - 121
12345